Analysts/Gary Nachman

Gary Nachman

Healthcare

Limited coverage. Only 1 question of coverage. Treat these numbers as directional — sample too small for reliable averages.

1

Companies

1

Questions

Focus Areas2 topics

Competitive Dynamics1Revenue Growth1

Question History1 questions

ABBVAbbVie1 quarter

2025 Q2

What are you seeing regarding the competitive dynamics in the IL-23 class, especially with J&J's TREMFYA with their new IBD approvals

Competitive DynamicsRevenue GrowthView in transcript →